Disk Diffusion Method for Antimicrobial Susceptibility Testing: Protocol and Interpretation

The disk diffusion method, also known as the Kirby-Bauer test, is a standardized, qualitative antimicrobial susceptibility testing (AST) technique that measures the inhibition of bacterial growth around antibiotic-impregnated paper disks on an agar plate. This method is useful for rapidly determining whether a bacterial isolate is susceptible, intermediate, or resistant to a panel of antimicrobial agents, guiding empirical therapy and surveillance of antimicrobial resistance patterns. It is widely employed in clinical, research, and teaching laboratories due to its simplicity, cost-effectiveness, and reproducibility when performed under strict standardized conditions. The method does not provide a minimum inhibitory concentration (MIC) but yields zone diameter measurements that are interpreted using established breakpoints from organizations such as the Clinical and Laboratory Standards Institute (CLSI) or the European Committee on Antimicrobial Susceptibility Testing (EUCAST).

At a Glance

Scientific Principle of Disk Diffusion

The disk diffusion method relies on the diffusion of an antimicrobial agent from a paper disk into the surrounding agar medium, establishing a concentration gradient. After incubation, bacterial growth is visible as a lawn on the agar surface, except in areas where the antibiotic concentration exceeds the minimum inhibitory concentration for that organism. The resulting zone of inhibition—a clear, circular area around the disk—is measured in millimeters. The diameter of this zone is inversely related to the MIC: larger zones indicate greater susceptibility, while smaller or absent zones suggest resistance.

The method is based on the principle that the antibiotic diffuses radially at a rate dependent on its molecular weight, solubility, and the agar composition. The critical concentration at the edge of the zone corresponds to the MIC for that organism under the test conditions. This relationship allows zone diameters to be correlated with clinical breakpoints established through large-scale studies correlating in vitro results with clinical outcomes and pharmacokinetic/pharmacodynamic data [1][3]. For example, the 2025 CLSI breakpoint revisions for minocycline against Acinetobacter baumannii complex were validated by comparing disk diffusion zone diameters with broth microdilution MICs, demonstrating improved categorical agreement from 64.1% to 90.9% after revision [1].

Materials and Instrumentation Choices

Agar Medium

Mueller-Hinton agar (MHA) is the standard medium for disk diffusion testing. Its composition—beef infusion, casein hydrolysate, and starch—provides consistent physical and chemical properties that support reproducible antibiotic diffusion and bacterial growth. Key considerations include:

• pH: Must be 7.2–7.4 at room temperature. Deviations affect antibiotic activity (e.g., tetracyclines are less active at acidic pH).
• Depth: Pour plates to a uniform depth of 4 mm (approximately 25 mL per 100 mm plate). Shallow agar leads to larger zones; deep agar reduces diffusion.
• Cations: MHA contains low levels of thymidine and sulfonamide inhibitors. For testing sulfonamides or trimethoprim, use thymidine-free MHA.
• Supplementation: For fastidious organisms (e.g., Haemophilus influenzae, Neisseria gonorrhoeae), use supplemented MHA (e.g., with 5% defibrinated sheep blood, NAD, or hemin).

Antibiotic Disks

Commercially prepared disks contain specified concentrations of antimicrobial agents (e.g., 30 µg for cefiderocol, 10 µg for imipenem). Disks must be stored at -20°C or 2–8°C in sealed desiccated containers to prevent degradation. Allow disks to equilibrate to room temperature before opening to avoid condensation. Never use expired disks, as reduced potency leads to falsely small zones.

Inoculum Standardization

A 0.5 McFarland turbidity standard is essential for preparing a standardized bacterial suspension. This corresponds to approximately 1.5 × 10⁸ colony-forming units (CFU)/mL. Use a photometric device (turbidimeter) or visual comparison against a barium sulfate standard. Over-inoculation produces confluent growth with falsely small zones; under-inoculation yields sparse growth and falsely large zones.

Swabs and Forceps

Use sterile cotton or synthetic swabs for lawn inoculation. Forceps or a disk dispenser should be used to place disks; avoid touching disks with bare hands to prevent contamination and antibiotic degradation.

Measurement Tools

Zone diameters are measured to the nearest millimeter using a caliper, ruler, or automated imaging system. Automated systems, such as those employing YOLO11n object detection models, have demonstrated high accuracy (R² = 0.98) with a mean absolute error of 0.42 mm in zone diameter prediction, offering potential for high-throughput, standardized reading [2].

Quality Control and Reference Strains

Quality control (QC) is mandatory for every batch of tests. Use reference strains with known susceptibility patterns to validate the performance of the medium, disks, and technique. Common QC strains include:

• Escherichia coli ATCC 25922 (for Gram-negative antibiotics)
• Staphylococcus aureus ATCC 25923 (for Gram-positive antibiotics)
• Pseudomonas aeruginosa ATCC 27853 (for antipseudomonal agents)
• Enterococcus faecalis ATCC 29212 (for vancomycin and high-level aminoglycosides)

QC zone diameters must fall within published acceptable ranges. If QC results are out of range, investigate potential causes: expired disks, contaminated medium, incorrect inoculum, or incubation errors. Document all QC results and corrective actions.

Conceptual Workflow

Step 1: Prepare the Inoculum

1. Select 3–5 well-isolated colonies of the test organism from an 18–24 hour pure culture.
2. Transfer colonies to 2–3 mL of sterile saline or Mueller-Hinton broth.
3. Adjust turbidity to 0.5 McFarland standard using a turbidimeter or visual comparison.
4. Use the suspension within 15 minutes to avoid cell death or growth.

Step 2: Inoculate the Agar Plate

1. Dip a sterile swab into the standardized suspension.
2. Rotate the swab against the tube wall to remove excess fluid.
3. Streak the swab evenly across the entire agar surface in three directions (horizontal, vertical, diagonal) to ensure confluent growth.
4. Allow the plate surface to dry for 3–5 minutes (no longer than 15 minutes) before applying disks.

Step 3: Apply Antibiotic Disks

1. Using sterile forceps or a disk dispenser, place disks firmly onto the agar surface. Ensure full contact; do not reposition disks once placed.
2. Space disks at least 24 mm apart (center to center) to prevent overlapping zones. A standard 100 mm plate can accommodate 5–6 disks.
3. Press each disk gently with forceps to ensure adherence.

Step 4: Incubate

1. Invert plates and incubate at 35 ± 2°C for 16–18 hours in ambient air.
2. For fastidious organisms (e.g., Streptococcus pneumoniae), incubate in 5% CO₂.
3. Do not stack plates more than 4 high to ensure uniform temperature.

Step 5: Measure Zone Diameters

1. Examine plates against a dark, non-reflective background with transmitted light.
2. Measure the diameter of each zone of inhibition to the nearest millimeter, including the disk.
3. For zones with sharp edges, measure at the point of complete inhibition. For swarming organisms (e.g., Proteus), measure the zone edge where growth is inhibited, ignoring the swarming film.
4. Record measurements on a worksheet or directly into a laboratory information system.

Step 6: Interpret Results

1. Compare measured zone diameters to the appropriate CLSI or EUCAST breakpoint table for the organism-antimicrobial combination.
2. Classify each result as Susceptible (S), Intermediate (I), or Resistant (R).
3. Note that breakpoints may vary by organism species and antimicrobial agent. For example, the 2025 CLSI breakpoints for minocycline against A. baumannii complex reduced the susceptibility rate from 73.9% to 46.4% and increased the resistance rate from 4.4% to 46.0%, reflecting updated clinical data [1].

Result Interpretation and Clinical Relevance

Zone diameter interpretation requires careful attention to the specific breakpoints published by CLSI or EUCAST. These breakpoints are periodically revised based on new clinical, microbiological, and pharmacokinetic data. For instance, the revision of minocycline breakpoints for A. baumannii complex in 2025 improved categorical agreement between disk diffusion and broth microdilution from 64.1% to 90.9%, demonstrating the importance of using current breakpoints [1].

Interpretation also depends on the organism-antimicrobial combination. For cefiderocol testing against blaNDM-producing Enterobacterales, disk diffusion using EUCAST breakpoints classified 94.7% of isolates as resistant, while CLSI breakpoints classified only 1.8% as resistant, highlighting substantial differences between interpretive criteria [3]. Similarly, nitroxoline disk diffusion for E. coli showed 96.2% susceptibility, but no established breakpoints exist for Klebsiella pneumoniae, limiting interpretation [4].

When zone diameters fall near breakpoint boundaries, consider repeating the test or performing a confirmatory MIC method (e.g., broth microdilution or gradient test). The "intermediate" category indicates that the antimicrobial may be effective at higher doses or at sites of infection where drug concentrations are elevated.

Troubleshooting Common Problems

Limitations of the Disk Diffusion Method

While disk diffusion is a valuable screening tool, it has several limitations:

• Qualitative only: It provides categorical results (S/I/R) but not MIC values, which are needed for precise dosing or detecting low-level resistance.
• Not suitable for all organisms: Slow-growing, fastidious, or anaerobic organisms require modified methods or alternative AST approaches.
• Breakpoint dependence: Interpretation relies on current CLSI or EUCAST breakpoints, which may differ between organizations and are periodically updated [1][3].
• Disk stability: Antibiotic disks are sensitive to temperature and humidity; improper storage leads to inaccurate results.
• Subjectivity in reading: Manual measurement of zone diameters introduces variability, though automated systems are improving reproducibility [2].
• Limited to single concentration: Each disk contains only one antibiotic concentration, which may not detect heteroresistance or inducible resistance mechanisms.

Documentation and Reporting

Accurate documentation is essential for reproducibility, quality assurance, and clinical decision-making. Record the following for each test:

• Organism identification and source
• Date and time of inoculation and reading
• Inoculum turbidity (0.5 McFarland)
• Medium lot number and expiration date
• Antibiotic disk names, concentrations, and lot numbers
• Zone diameters (mm) for each disk
• Interpretation (S/I/R) based on current breakpoints
• QC strain results and any corrective actions

Report results in a standardized format, typically listing each antimicrobial agent with its interpretation. For research or surveillance studies, include zone diameter measurements to allow re-interpretation if breakpoints change.

Biosafety Considerations

Disk diffusion testing is routinely performed at Biosafety Level 1 (BSL-1) for non-pathogenic teaching strains (e.g., E. coli ATCC 25922, S. aureus ATCC 25923). When testing clinical isolates or known pathogens, follow BSL-2 practices as outlined in the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL) 6th Edition [6]. Key biosafety measures include:

• Perform all manipulations in a biological safety cabinet (BSC) when handling clinical isolates.
• Wear appropriate personal protective equipment (lab coat, gloves, eye protection).
• Decontaminate all waste (plates, swabs, tubes) by autoclaving before disposal.
• Disinfect work surfaces before and after each session with an appropriate disinfectant (e.g., 10% bleach or 70% ethanol).
• Do not use the disk diffusion method for select agents or highly virulent pathogens without appropriate containment and institutional approval.

For research involving recombinant or synthetic nucleic acid molecules (e.g., engineered strains), follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [7]. Ensure institutional biosafety committee (IBC) approval before proceeding with any genetically modified organisms.

Frequently Asked Questions

1. Can I use the disk diffusion method for all bacterial species? No. Disk diffusion is standardized for rapidly growing aerobic and facultative anaerobic bacteria (e.g., Enterobacterales, staphylococci, pseudomonads). It is not recommended for anaerobes, slow-growing organisms (e.g., Mycobacterium spp.), or fastidious bacteria that require specialized media or incubation conditions. For these organisms, use MIC-based methods such as broth microdilution or agar dilution.

2. Why must I use Mueller-Hinton agar specifically? Mueller-Hinton agar provides consistent physical and chemical properties that support reproducible antibiotic diffusion and bacterial growth. Its low thymidine content minimizes interference with sulfonamide and trimethoprim testing. Alternative media may alter zone sizes and lead to inaccurate interpretations. Always use MHA from a reputable manufacturer and verify performance with QC strains.

3. How do I handle organisms that swarm (e.g., Proteus species)? Swarming can obscure zone edges. To minimize swarming, use a slightly drier agar surface (allow plates to dry for 30 minutes after pouring) and reduce inoculum density. When measuring zones, ignore the thin swarming film and measure the point where dense growth is inhibited. Some laboratories use swarming-inhibitory media (e.g., CLED agar), but this is not standard for disk diffusion.

4. What should I do if my QC results are out of range? First, verify that you used the correct QC strain, medium, disks, and incubation conditions. Repeat the test with fresh materials. If results remain out of range, investigate potential causes: expired disks, contaminated medium, incorrect inoculum, or incubator temperature deviation. Document all findings and corrective actions. Do not report patient or research results until QC is within acceptable ranges.

References and Further Reading

1. Yu X, Liu Y, Du J, Hu F, Yin D. Assessment of the revision of the 2025 CLSI breakpoints for the interpretation of minocycline susceptibility for Acinetobacter baumannii complex. 2026. PubMed ID: 41685899. Link
2. Ciftci F, Erarslan A, Rahebi J. Automatic detection and quantification of antimicrobial inhibition zones using YOLO11n with post-hoc interpretability validation. 2026. PubMed ID: 42131204. Link
3. Duggan C, Cantillon D, Lawrie D, et al. Comparison of multiple cefiderocol susceptibility testing methods against genomic determinants of resistance in blaNDM carbapenemase producing Enterobacterales. 2026. DOI: 10.64898/2026.01.27.701980. Link
4. Maleš D, Barišić Z, Kero D, Carev M. Contrasting In Vitro Activity of Nitroxoline Against Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae Isolates from Outpatients. 2026. PubMed ID: 42192701. Link
5. Bölükbaşı Y, Öngen B. In Vitro Activity of Cefiderocol, Eravacycline, and Imipenem-Relebactam Against Multidrug-Resistant Acinetobacter baumannii Clinical Isolates. 2026. PubMed ID: 41892408. Link
6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. Link
7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Link
8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. Link

Related Articles

• Comparison of Disk Diffusion and Broth Microdilution for Antimicrobial Susceptibility Testing
• How to Interpret Zone Diameter Measurements in Disk Diffusion Susceptibility Testing
• Common Sources of Error in Disk Diffusion Susceptibility Testing and How to Avoid Them
• Understanding CLSI Breakpoints for Disk Diffusion and MIC Interpretation
• How to Design a Reproducible Disk Diffusion Susceptibility Test Protocol
• Common Errors in Disk Diffusion Testing and How to Avoid Them